In a separate study, artificial amplification of HER2 cDNA in a non-tumor breast epithelial cell line, HB4a, forced the upregulation of lipogenic fatty acid translocase (CD36), fatty acid-binding protein 4 (FABP4) and FASN expression. Here, ERBB2 is linked to neoplasm.